Recombinant human thrombin protein is a laboratory-produced form of the human thrombin enzyme, which plays a crucial role in blood clotting. This recombinant version is created through genetic engineering techniques, often using bacteria or yeast to produce the protein. It's used in medical settings for various purposes, such as controlling bleeding during surgery or as a diagnostic tool.

The global Recombinant Human Thrombin Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Recombinant Human Thrombin Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Recombinant Human Thrombin Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Recombinant Human Thrombin Protein include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Thrombin Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Thrombin Protein.

The Recombinant Human Thrombin Protein market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Recombinant Human Thrombin Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Thrombin Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Human Thrombin Protein Market Report

Report Metric	Details
Report Name	Recombinant Human Thrombin Protein Market
Segment by Type	Based Bovine Based Human Others
Segment by Application	Hospitals Clinics Academic and Research Institute
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, Shanghai RAAS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Thrombin Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Thrombin Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Human Thrombin Protein Market report?

Ans: The main players in the Recombinant Human Thrombin Protein Market are Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, Shanghai RAAS

What are the Application segmentation covered in the Recombinant Human Thrombin Protein Market report?

Ans: The Applications covered in the Recombinant Human Thrombin Protein Market report are Hospitals, Clinics, Academic and Research Institute

What are the Type segmentation covered in the Recombinant Human Thrombin Protein Market report?

Ans: The Types covered in the Recombinant Human Thrombin Protein Market report are Based Bovine, Based Human, Others

1 Recombinant Human Thrombin Protein Market Overview

1.1 Product Definition

1.2 Recombinant Human Thrombin Protein by Type

1.2.1 Global Recombinant Human Thrombin Protein Market Value Comparison by Type (2024-2030)

1.2.2 Based Bovine

1.2.3 Based Human

1.2.4 Others

1.3 Recombinant Human Thrombin Protein by Application

1.3.1 Global Recombinant Human Thrombin Protein Market Value by Application (2024-2030)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Academic and Research Institute

1.4 Global Recombinant Human Thrombin Protein Market Size Estimates and Forecasts

1.4.1 Global Recombinant Human Thrombin Protein Revenue 2019-2030

1.4.2 Global Recombinant Human Thrombin Protein Sales 2019-2030

1.4.3 Global Recombinant Human Thrombin Protein Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Recombinant Human Thrombin Protein Market Competition by Manufacturers

2.1 Global Recombinant Human Thrombin Protein Sales Market Share by Manufacturers (2019-2024)

2.2 Global Recombinant Human Thrombin Protein Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Recombinant Human Thrombin Protein Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Recombinant Human Thrombin Protein, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Recombinant Human Thrombin Protein, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Human Thrombin Protein, Product Type & Application

2.7 Global Key Manufacturers of Recombinant Human Thrombin Protein, Date of Enter into This Industry

2.8 Global Recombinant Human Thrombin Protein Market Competitive Situation and Trends

2.8.1 Global Recombinant Human Thrombin Protein Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Recombinant Human Thrombin Protein Players Market Share by Revenue

2.8.3 Global Recombinant Human Thrombin Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Recombinant Human Thrombin Protein Market Scenario by Region

3.1 Global Recombinant Human Thrombin Protein Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Recombinant Human Thrombin Protein Sales by Region: 2019-2030

3.2.1 Global Recombinant Human Thrombin Protein Sales by Region: 2019-2024

3.2.2 Global Recombinant Human Thrombin Protein Sales by Region: 2025-2030

3.3 Global Recombinant Human Thrombin Protein Revenue by Region: 2019-2030

3.3.1 Global Recombinant Human Thrombin Protein Revenue by Region: 2019-2024

3.3.2 Global Recombinant Human Thrombin Protein Revenue by Region: 2025-2030

3.4 North America Recombinant Human Thrombin Protein Market Facts & Figures by Country

3.4.1 North America Recombinant Human Thrombin Protein Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Recombinant Human Thrombin Protein Sales by Country (2019-2030)

3.4.3 North America Recombinant Human Thrombin Protein Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Recombinant Human Thrombin Protein Market Facts & Figures by Country

3.5.1 Europe Recombinant Human Thrombin Protein Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Recombinant Human Thrombin Protein Sales by Country (2019-2030)

3.5.3 Europe Recombinant Human Thrombin Protein Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Human Thrombin Protein Market Facts & Figures by Region

3.6.1 Asia Pacific Recombinant Human Thrombin Protein Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Recombinant Human Thrombin Protein Sales by Region (2019-2030)

3.6.3 Asia Pacific Recombinant Human Thrombin Protein Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Recombinant Human Thrombin Protein Market Facts & Figures by Country

3.7.1 Latin America Recombinant Human Thrombin Protein Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Recombinant Human Thrombin Protein Sales by Country (2019-2030)

3.7.3 Latin America Recombinant Human Thrombin Protein Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Recombinant Human Thrombin Protein Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Human Thrombin Protein Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Recombinant Human Thrombin Protein Sales by Country (2019-2030)

3.8.3 Middle East and Africa Recombinant Human Thrombin Protein Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Recombinant Human Thrombin Protein Sales by Type (2019-2030)

4.1.1 Global Recombinant Human Thrombin Protein Sales by Type (2019-2024)

4.1.2 Global Recombinant Human Thrombin Protein Sales by Type (2025-2030)

4.1.3 Global Recombinant Human Thrombin Protein Sales Market Share by Type (2019-2030)

4.2 Global Recombinant Human Thrombin Protein Revenue by Type (2019-2030)

4.2.1 Global Recombinant Human Thrombin Protein Revenue by Type (2019-2024)

4.2.2 Global Recombinant Human Thrombin Protein Revenue by Type (2025-2030)

4.2.3 Global Recombinant Human Thrombin Protein Revenue Market Share by Type (2019-2030)

4.3 Global Recombinant Human Thrombin Protein Price by Type (2019-2030)

5 Segment by Application

5.1 Global Recombinant Human Thrombin Protein Sales by Application (2019-2030)

5.1.1 Global Recombinant Human Thrombin Protein Sales by Application (2019-2024)

5.1.2 Global Recombinant Human Thrombin Protein Sales by Application (2025-2030)

5.1.3 Global Recombinant Human Thrombin Protein Sales Market Share by Application (2019-2030)

5.2 Global Recombinant Human Thrombin Protein Revenue by Application (2019-2030)

5.2.1 Global Recombinant Human Thrombin Protein Revenue by Application (2019-2024)

5.2.2 Global Recombinant Human Thrombin Protein Revenue by Application (2025-2030)

5.2.3 Global Recombinant Human Thrombin Protein Revenue Market Share by Application (2019-2030)

5.3 Global Recombinant Human Thrombin Protein Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Takeda

6.1.1 Takeda Company Information

6.1.2 Takeda Description and Business Overview

6.1.3 Takeda Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Takeda Recombinant Human Thrombin Protein Product Portfolio

6.1.5 Takeda Recent Developments/Updates

6.2 Bayer

6.2.1 Bayer Company Information

6.2.2 Bayer Description and Business Overview

6.2.3 Bayer Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bayer Recombinant Human Thrombin Protein Product Portfolio

6.2.5 Bayer Recent Developments/Updates

6.3 CSL

6.3.1 CSL Company Information

6.3.2 CSL Description and Business Overview

6.3.3 CSL Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.3.4 CSL Recombinant Human Thrombin Protein Product Portfolio

6.3.5 CSL Recent Developments/Updates

6.4 Grifols

6.4.1 Grifols Company Information

6.4.2 Grifols Description and Business Overview

6.4.3 Grifols Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Grifols Recombinant Human Thrombin Protein Product Portfolio

6.4.5 Grifols Recent Developments/Updates

6.5 GE Healthcare

6.5.1 GE Healthcare Company Information

6.5.2 GE Healthcare Description and Business Overview

6.5.3 GE Healthcare Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GE Healthcare Recombinant Human Thrombin Protein Product Portfolio

6.5.5 GE Healthcare Recent Developments/Updates

6.6 Hualan Biological

6.6.1 Hualan Biological Company Information

6.6.2 Hualan Biological Description and Business Overview

6.6.3 Hualan Biological Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Hualan Biological Recombinant Human Thrombin Protein Product Portfolio

6.6.5 Hualan Biological Recent Developments/Updates

6.7 Haematologic Technologies

6.7.1 Haematologic Technologies Company Information

6.7.2 Haematologic Technologies Description and Business Overview

6.7.3 Haematologic Technologies Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Haematologic Technologies Recombinant Human Thrombin Protein Product Portfolio

6.7.5 Haematologic Technologies Recent Developments/Updates

6.8 Pfizer

6.8.1 Pfizer Company Information

6.8.2 Pfizer Description and Business Overview

6.8.3 Pfizer Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Pfizer Recombinant Human Thrombin Protein Product Portfolio

6.8.5 Pfizer Recent Developments/Updates

6.9 Octapharma

6.9.1 Octapharma Company Information

6.9.2 Octapharma Description and Business Overview

6.9.3 Octapharma Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Octapharma Recombinant Human Thrombin Protein Product Portfolio

6.9.5 Octapharma Recent Developments/Updates

6.10 Omrix Biopharmaceuticals

6.10.1 Omrix Biopharmaceuticals Company Information

6.10.2 Omrix Biopharmaceuticals Description and Business Overview

6.10.3 Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Product Portfolio

6.10.5 Omrix Biopharmaceuticals Recent Developments/Updates

6.11 Shanghai RAAS

6.11.1 Shanghai RAAS Company Information

6.11.2 Shanghai RAAS Description and Business Overview

6.11.3 Shanghai RAAS Recombinant Human Thrombin Protein Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Shanghai RAAS Recombinant Human Thrombin Protein Product Portfolio

6.11.5 Shanghai RAAS Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Recombinant Human Thrombin Protein Industry Chain Analysis

7.2 Recombinant Human Thrombin Protein Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Human Thrombin Protein Production Mode & Process

7.4 Recombinant Human Thrombin Protein Sales and Marketing

7.4.1 Recombinant Human Thrombin Protein Sales Channels

7.4.2 Recombinant Human Thrombin Protein Distributors

7.5 Recombinant Human Thrombin Protein Customers

8 Recombinant Human Thrombin Protein Market Dynamics

8.1 Recombinant Human Thrombin Protein Industry Trends

8.2 Recombinant Human Thrombin Protein Market Drivers

8.3 Recombinant Human Thrombin Protein Market Challenges

8.4 Recombinant Human Thrombin Protein Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Haematologic Technologies

Pfizer Inc

Octapharma AG

OMRIX Biopharmaceuticals

Shanghai Raas

List of Tables

Table 1. Global Recombinant Human Thrombin Protein Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Recombinant Human Thrombin Protein Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Recombinant Human Thrombin Protein Market Competitive Situation by Manufacturers in 2023

Table 4. Global Recombinant Human Thrombin Protein Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Recombinant Human Thrombin Protein Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Recombinant Human Thrombin Protein Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Recombinant Human Thrombin Protein Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Recombinant Human Thrombin Protein Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Recombinant Human Thrombin Protein, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Recombinant Human Thrombin Protein, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Recombinant Human Thrombin Protein, Product Type & Application

Table 12. Global Key Manufacturers of Recombinant Human Thrombin Protein, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Recombinant Human Thrombin Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Thrombin Protein as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Recombinant Human Thrombin Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Recombinant Human Thrombin Protein Sales by Region (2019-2024) & (K Units)

Table 18. Global Recombinant Human Thrombin Protein Sales Market Share by Region (2019-2024)

Table 19. Global Recombinant Human Thrombin Protein Sales by Region (2025-2030) & (K Units)

Table 20. Global Recombinant Human Thrombin Protein Sales Market Share by Region (2025-2030)

Table 21. Global Recombinant Human Thrombin Protein Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Recombinant Human Thrombin Protein Revenue Market Share by Region (2019-2024)

Table 23. Global Recombinant Human Thrombin Protein Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Recombinant Human Thrombin Protein Revenue Market Share by Region (2025-2030)

Table 25. North America Recombinant Human Thrombin Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Recombinant Human Thrombin Protein Sales by Country (2019-2024) & (K Units)

Table 27. North America Recombinant Human Thrombin Protein Sales by Country (2025-2030) & (K Units)

Table 28. North America Recombinant Human Thrombin Protein Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Recombinant Human Thrombin Protein Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Recombinant Human Thrombin Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Recombinant Human Thrombin Protein Sales by Country (2019-2024) & (K Units)

Table 32. Europe Recombinant Human Thrombin Protein Sales by Country (2025-2030) & (K Units)

Table 33. Europe Recombinant Human Thrombin Protein Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Recombinant Human Thrombin Protein Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Recombinant Human Thrombin Protein Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Recombinant Human Thrombin Protein Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Recombinant Human Thrombin Protein Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Recombinant Human Thrombin Protein Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Recombinant Human Thrombin Protein Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Recombinant Human Thrombin Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Recombinant Human Thrombin Protein Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Recombinant Human Thrombin Protein Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Recombinant Human Thrombin Protein Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Recombinant Human Thrombin Protein Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Recombinant Human Thrombin Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Recombinant Human Thrombin Protein Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Recombinant Human Thrombin Protein Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Recombinant Human Thrombin Protein Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Recombinant Human Thrombin Protein Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Recombinant Human Thrombin Protein Sales (K Units) by Type (2019-2024)

Table 51. Global Recombinant Human Thrombin Protein Sales (K Units) by Type (2025-2030)

Table 52. Global Recombinant Human Thrombin Protein Sales Market Share by Type (2019-2024)

Table 53. Global Recombinant Human Thrombin Protein Sales Market Share by Type (2025-2030)

Table 54. Global Recombinant Human Thrombin Protein Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Recombinant Human Thrombin Protein Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Recombinant Human Thrombin Protein Revenue Market Share by Type (2019-2024)

Table 57. Global Recombinant Human Thrombin Protein Revenue Market Share by Type (2025-2030)

Table 58. Global Recombinant Human Thrombin Protein Price (US$/Unit) by Type (2019-2024)

Table 59. Global Recombinant Human Thrombin Protein Price (US$/Unit) by Type (2025-2030)

Table 60. Global Recombinant Human Thrombin Protein Sales (K Units) by Application (2019-2024)

Table 61. Global Recombinant Human Thrombin Protein Sales (K Units) by Application (2025-2030)

Table 62. Global Recombinant Human Thrombin Protein Sales Market Share by Application (2019-2024)

Table 63. Global Recombinant Human Thrombin Protein Sales Market Share by Application (2025-2030)

Table 64. Global Recombinant Human Thrombin Protein Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Recombinant Human Thrombin Protein Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Recombinant Human Thrombin Protein Revenue Market Share by Application (2019-2024)

Table 67. Global Recombinant Human Thrombin Protein Revenue Market Share by Application (2025-2030)

Table 68. Global Recombinant Human Thrombin Protein Price (US$/Unit) by Application (2019-2024)

Table 69. Global Recombinant Human Thrombin Protein Price (US$/Unit) by Application (2025-2030)

Table 70. Takeda Company Information

Table 71. Takeda Description and Business Overview

Table 72. Takeda Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Takeda Recombinant Human Thrombin Protein Product

Table 74. Takeda Recent Developments/Updates

Table 75. Bayer Company Information

Table 76. Bayer Description and Business Overview

Table 77. Bayer Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Bayer Recombinant Human Thrombin Protein Product

Table 79. Bayer Recent Developments/Updates

Table 80. CSL Company Information

Table 81. CSL Description and Business Overview

Table 82. CSL Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. CSL Recombinant Human Thrombin Protein Product

Table 84. CSL Recent Developments/Updates

Table 85. Grifols Company Information

Table 86. Grifols Description and Business Overview

Table 87. Grifols Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Grifols Recombinant Human Thrombin Protein Product

Table 89. Grifols Recent Developments/Updates

Table 90. GE Healthcare Company Information

Table 91. GE Healthcare Description and Business Overview

Table 92. GE Healthcare Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. GE Healthcare Recombinant Human Thrombin Protein Product

Table 94. GE Healthcare Recent Developments/Updates

Table 95. Hualan Biological Company Information

Table 96. Hualan Biological Description and Business Overview

Table 97. Hualan Biological Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Hualan Biological Recombinant Human Thrombin Protein Product

Table 99. Hualan Biological Recent Developments/Updates

Table 100. Haematologic Technologies Company Information

Table 101. Haematologic Technologies Description and Business Overview

Table 102. Haematologic Technologies Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Haematologic Technologies Recombinant Human Thrombin Protein Product

Table 104. Haematologic Technologies Recent Developments/Updates

Table 105. Pfizer Company Information

Table 106. Pfizer Description and Business Overview

Table 107. Pfizer Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Pfizer Recombinant Human Thrombin Protein Product

Table 109. Pfizer Recent Developments/Updates

Table 110. Octapharma Company Information

Table 111. Octapharma Description and Business Overview

Table 112. Octapharma Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Octapharma Recombinant Human Thrombin Protein Product

Table 114. Octapharma Recent Developments/Updates

Table 115. Omrix Biopharmaceuticals Company Information

Table 116. Omrix Biopharmaceuticals Description and Business Overview

Table 117. Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Product

Table 119. Omrix Biopharmaceuticals Recent Developments/Updates

Table 120. Shanghai RAAS Company Information

Table 121. Shanghai RAAS Description and Business Overview

Table 122. Shanghai RAAS Recombinant Human Thrombin Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Shanghai RAAS Recombinant Human Thrombin Protein Product

Table 124. Shanghai RAAS Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Recombinant Human Thrombin Protein Distributors List

Table 128. Recombinant Human Thrombin Protein Customers List

Table 129. Recombinant Human Thrombin Protein Market Trends

Table 130. Recombinant Human Thrombin Protein Market Drivers

Table 131. Recombinant Human Thrombin Protein Market Challenges

Table 132. Recombinant Human Thrombin Protein Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Recombinant Human Thrombin Protein

Figure 2. Global Recombinant Human Thrombin Protein Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Recombinant Human Thrombin Protein Market Share by Type: 2023 & 2030

Figure 4. Based Bovine Product Picture

Figure 5. Based Human Product Picture

Figure 6. Others Product Picture

Figure 7. Global Recombinant Human Thrombin Protein Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Recombinant Human Thrombin Protein Market Share by Application: 2023 & 2030

Figure 9. Hospitals

Figure 10. Clinics

Figure 11. Academic and Research Institute

Figure 12. Global Recombinant Human Thrombin Protein Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Recombinant Human Thrombin Protein Market Size (2019-2030) & (US$ Million)

Figure 14. Global Recombinant Human Thrombin Protein Sales (2019-2030) & (K Units)

Figure 15. Global Recombinant Human Thrombin Protein Average Price (US$/Unit) & (2019-2030)

Figure 16. Recombinant Human Thrombin Protein Report Years Considered

Figure 17. Recombinant Human Thrombin Protein Sales Share by Manufacturers in 2023

Figure 18. Global Recombinant Human Thrombin Protein Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Recombinant Human Thrombin Protein Players: Market Share by Revenue in Recombinant Human Thrombin Protein in 2023

Figure 20. Recombinant Human Thrombin Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Recombinant Human Thrombin Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Recombinant Human Thrombin Protein Sales Market Share by Country (2019-2030)

Figure 23. North America Recombinant Human Thrombin Protein Revenue Market Share by Country (2019-2030)

Figure 24. United States Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Recombinant Human Thrombin Protein Sales Market Share by Country (2019-2030)

Figure 27. Europe Recombinant Human Thrombin Protein Revenue Market Share by Country (2019-2030)

Figure 28. Germany Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Recombinant Human Thrombin Protein Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Recombinant Human Thrombin Protein Revenue Market Share by Region (2019-2030)

Figure 35. China Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Recombinant Human Thrombin Protein Sales Market Share by Country (2019-2030)

Figure 43. Mexico Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Recombinant Human Thrombin Protein Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Recombinant Human Thrombin Protein Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Recombinant Human Thrombin Protein Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Recombinant Human Thrombin Protein by Type (2019-2030)

Figure 53. Global Revenue Market Share of Recombinant Human Thrombin Protein by Type (2019-2030)

Figure 54. Global Recombinant Human Thrombin Protein Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Recombinant Human Thrombin Protein by Application (2019-2030)

Figure 56. Global Revenue Market Share of Recombinant Human Thrombin Protein by Application (2019-2030)

Figure 57. Global Recombinant Human Thrombin Protein Price (US$/Unit) by Application (2019-2030)

Figure 58. Recombinant Human Thrombin Protein Value Chain

Figure 59. Recombinant Human Thrombin Protein Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Thrombin Market Research Report 2024

Global Topical Recombinant Human Thrombin Market Research Report 2024

Antithrombin Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Hirudin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Topical Recombinant Thrombin Market Research Report 2024

Global Human Coagulation Factor VII Market Insights Forecast to 2030

Global Management of Antithrombin Market Research Report 2024

Antithrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non recombinant Coagulation Factors Market Research Report 2024

Global Gene Recombinant Protein Market Research Report 2024

Global Recombinant Therapeutic Protein Market Research Report 2025

Global Recombinant Protein Expression System Market Research Report 2024

Humanes Antithrombin III Konzentrat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Proteins Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Recombinant Plasma Proteins Market Insights Forecast to 2030

Global Recombinant Porcine Trypsin Market Research Report 2024

Global Recombinant Trypsin Market Insights Forecast to 2030

Global Thrombin Inhibitor Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions